Found: 18
Select item for more details and to access through your institution.
Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 3, p. N.PAG, doi. 10.1016/j.clgc.2024.02.007
- By:
- Publication type:
- Article
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 1, p. 53, doi. 10.1016/j.clgc.2021.11.004
- By:
- Publication type:
- Article
The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 Expression.
- Published in:
- Cancers, 2023, v. 15, n. 24, p. 5721, doi. 10.3390/cancers15245721
- By:
- Publication type:
- Article
Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2867, doi. 10.3390/cancers14122867
- By:
- Publication type:
- Article
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.701345
- By:
- Publication type:
- Article
Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.622134
- By:
- Publication type:
- Article
Adjuvant Therapy for Non–Clear Cell Renal Cell Carcinoma—The Ascent Continues.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.779915
- By:
- Publication type:
- Article
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1072, doi. 10.1093/oncolo/oyad154
- By:
- Publication type:
- Article
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 239, doi. 10.1093/oncolo/oyac236
- By:
- Publication type:
- Article
Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
- Published in:
- Oncologist, 2022, v. 27, n. 6, p. 462, doi. 10.1093/oncolo/oyac061
- By:
- Publication type:
- Article
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. 1017, doi. 10.1002/onco.13922
- By:
- Publication type:
- Article
Immune‐Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1742, doi. 10.1002/onco.13868
- By:
- Publication type:
- Article
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 397, doi. 10.1002/onco.13727
- By:
- Publication type:
- Article
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e528, doi. 10.1634/theoncologist.2019-0751
- By:
- Publication type:
- Article
Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah’s witness: A case report.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.949400
- By:
- Publication type:
- Article
PD‐L1 and nectin‐4 expression and genomic characterization of bladder cancer with divergent differentiation.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 21, p. 3658, doi. 10.1002/cncr.35465
- By:
- Publication type:
- Article
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3884, doi. 10.1002/cncr.34982
- By:
- Publication type:
- Article